14 Oct 2025

NCAP Medical Delivers Hands-On Clinical Training and Showcases Double-Blind NIH-Funded TKA Study Data at the 2025 ASA Annual Meeting

Public Events, Scientific Conference Event,
NCAP Medical, Inc. was proud to exhibit at the 2025 American Society of Anesthesiologists (ASA) Annual Meeting, where we showcased emerging scientific evidence from our ongoing NIH-funded, double-blind randomized study conducted at the University of Pittsburgh Pittsburgh Medical Center (UPMC)..Event information: https://www.asahq.org/Our exhibit featured a comprehensive research overview, including:Preliminary double-blind randomized and sham controlled results from the latest NIH-funded TKA outcomes trialFindings from previous peer-reviewed studies evaluating neuro-capacitive pain modulationOn-site hands-on demonstrations allowing clinicians to evaluate placement, workflow, and usability directlyAbout the NIH-Funded Double-Blind StudyThe ongoing study investigates a non-pharmacologic, neuro-capacitive adjunct for postoperative recovery following primary total knee arthroplasty…
Read More
10 Aug 2025

NCAP Medical Presents Preliminary NIH-Funded TKA Study Results at MHSRS 2025

Public Events, Published Peer-Reviewed Research
NCAP Medical, Inc. is pleased to announce that our Chief Medical Officer, Senthil Sadhasivam, MD, MBA, MPH, presented a scientific poster containing preliminary results from our ongoing NIH-funded total knee arthroplasty (TKA) outcome study, currently being conducted at the University of Pittsburgh Medical Center (UPMC). The work was featured at the Military Health System Research Symposium (MHSRS) — the Department of Defense’s premier multidisciplinary research meeting dedicated to optimizing the health and performance of U.S. service members. The event details can be found at the official MHSRS site:https://mhsrs.health.mil/ Background and Study Rationale Total knee arthroplasty remains one of the most…
Read More